Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Cannabinoids associated with negative respiratory health effects in older adults with COPD
2 Two Phase 3 Trials of Ensifentrine in Safely Treating COPD to Open
3 Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
4 Assessing COPD Using PROs and Exercise Test Outcomes
5 COPD May Increase Risk of All-Cause Mortality Among Patients With Heart Failure
6 Predicting COPD Exacerbations With Remote Patient Monitoring
7 Research shows the validity, reliability of isokinetic strength testing of older adults with COPD and stroke
8 Patients with chronic hypercapnic COPD may benefit from nasal high-flow therapy
9 Dying Patients With COPD Subjected to Testing Despite Shift to Comfort Care, Study Finds
10 COPD Patient Personalities Linked to Physical Activity Levels
11 Acute COPD Exacerbation Frequency May Not Be Accurate Guide for Treatment
12 Aspergillosis Linked to Higher-than-estimated COPD Deaths, Review Says
13 Antiplatelet Therapy in COPD May Reduce All-Cause Mortality, Improve Quality of Life
14 ATS: Clinical Practice Guidelines on the Pharmacologic Management of COPD
15 Letter to the Editor, International Journal of COPD [Letter] | COPD
16 Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
17 Low-dose Morphine Improves Health in COPD Patients With Shortness...
18 Repurposing a COPD drug for Covid-19 with Verona Pharma
19 4 Questions About Mucin Abnormalities in Early COPD
20 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Latest Research Report 2020 – Top Manufaturer and Vendors Covered, Regional & Global Analysis, Business Growth at CAGR of 3.79% During Forecast Period
21 Interstitial Lung Abnormalities Linked to Clinical Course in COPD
22 Verona Pharma launches late-stage COPD trial programme
23 Oral Sustained-Release Morphine May Improve Moderate, Severe Breathlessness in COPD
24 Lars Andersson, PhD: Identifying Mediators in Asthma and COPD Patients
25 Anti-Asthmatics And COPD Drugs Global Market Report 2020-30: Covid 19 Implications and Growth
26 Nocturnal Oxygen in COPD | NEJM
27 Homocysteine Level Tied to COPD Severity, Study Says
28 Verona Pharma Initiates Phase 3 Clinical Trials with Nebulized Ensifentrine for the Maintenance Treatment of COPD
29 Risk Factors for Acute Exacerbation of Chronic Obstructive Pulmonary D | COPD
30 Early intervention key to treating COPD
31 Agreement Reached for Hemp Facility to Support Potential COPD...
32 Inhaled corticosteroids and COVID-19-related mortality: confounding or clarifying?
33 Positive COPD data for Synairgen's SNG001 supports COVID-19 programme
34 Non-invasive ventilation with pursed lips breathing mode for patients with COPD and hypercapnic respiratory failure: A retrospective analysis
35 Dual Bronchodilator and Anti-Inflammatory COPD Drug Offers Potential for COVID-19 Treatment
36 No benefit of retreatment with ciprofloxacin for incompletely resolved COPD exacerbations
37 Copd And Asthma Devices Market Potential Growth, Size, Share, Demand and Analysis of Key Players – Research Forecasts to 2027
38 Boehringer Ingelheim Gets COPD Inhaler Class Action Tossed
39 COPD program decreases 30-day hospital readmission, may increase mortality
40 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market 2020, Research Report Covers Updated Data Considering Post Impact of Covid-19 on Share, Size and Future Demand With Profiling Eminent Players
41 Inhaled corticosteroids may not increase COVID-19 mortality
42 Understanding Clinicians' Perceived Barriers and Facilitators to | COPD
43 Verona (VRNA) Initiates Pivotal COPD Studies on Ensifentrine
44 Briefcase: Sept. 30, 2020 | Business, Finance & Technology
45 Global Aerosol delivery devices market to Hit $46.72 Billion by 2027: AMR
46 Vascular Calcification in COPD Affects Bone Mineral Density, Increases Fractures
47 Historic Ebenezer Baptist Church to offer free COVID-19, asthma & COPD testing Saturday
48 Dr Neal Jain Discusses Type 2 Inflammation in Asthma
50 COVID-19 Impact Analysis for Chronic Obstructive Pulmonary Disease (COPD) Drugs Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Mereo BioPharma, Pharmaxis, Pearl Therapeutics, F. Hoffmann-La Roche, Asmacure
51 Smart Inhalers: Global Markets
52 Asthma and COPD Drugs Market – Application Analysis by 2025
53 From coughs to COVID-19: Various symptoms can be signs of the virus or illness from tobacco use
54 FDA advisory panel does not back mortality risk-reduction update to Trelegy Ellipta label
55 BioSTL's international recruitment arm goes virtual for innovation summit — with focus on a new strategy
56 Asthma and COPD Drugs Market Size Forecast 2020 to 2024 | Industry Top Key Players, Trends, Dynamics, Growth Statistics, Opportunities by Business Plans
57 Sikkim artist wins ‘Women with COPD Art Contest’
58 'I'll see you later': Prolific artist Frank Ferguson bids farewell after longtime battle with COPD
59 Respiratory Effectiveness Group: Exemptions of respiratory patients to use face masks are not evidence-based, and it may carry associated risks of severe COVID-19
60 GlaxoSmithKline eyes novel death-risk reduction update to Trelegy's label, but analysts say the FDA may not be impressed
61 Wildfires, climate change and the air we breathe | TheHill
62 Synairgen plc
63 PAOG Cannabis Pharmaceutical Research Initiative Gains New Traction
64 Chronic Obstructive Pulmonary Disease Industry Analysis, COVID 19 Trends, Outlook, and Opportunity Analysis Up to 2026
65 Asthma & COPD Market Size, Regional Insights and Industry Dynamics By 2027 | By Top Leading Vendors – Novartis, GSK, Merck, Abbott, Boehringer Ingelheim, AstraZeneca, Roche
66 Asthma/COPD Combination Medication Market Size, Regional Insights and Industry Dynamics By 2027 | By Top Leading Vendors – Gsk, Astrazeneca, Boehringer Ingelheim Pharmaceuticals, Sunovion Pharmaceuticals Inc, Novartis, Circassia Pharmaceuticals Inc
67 Capnography Devices Market to Generate $713.3 Million Revenue by 2030: P&S Intelligence
68 Vets Study Casts Doubt on Accepted COVID-19 Risk Factors
69 Asthma & COPD Therapies Market: Increasing Demand for Research and Development Analysis Report till 2027
70 Pulmonx raises price range of its upsized IPO of 10M shares
71 SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic's COVID-19 registry
72 Coexisting COPD Increases Mortality in Patients With More Severe Asthma
73 Kentucky Voters Want Specific Issues Addressed in the Debate
74 What is Triple Therapy for COPD? An Expert Weighs In
75 COPD and Coronavirus: Symptoms, Risks, and More
76 Global Mechanical Ventilators Market Industry Analysis Size, In-depth Analysis, Volume, Trend, Growth and forecast 2017-2025
77 How a New Valve Therapy for COPD Helped One Patient Breathe Easier
78 What Are the Factors Predicting Mortality in Patients Using NIV for COPD?
79 Chronic Obstructive Pulmonary Disease Market Size 2020 | Analysis, Trends, Top Manufacturers, Growth, Statistics, Opportunities and Forecast to 2027
80 COPD and smoking associated with higher COVID-19 mortality
81 Copd Drugs Market Potential Growth, Size, Share, Demand and Analysis of Key Players – Research Forecasts to 2027
82 Understanding Early Predictors of Mortality in COPD
83 COPD and Concomitant COVID-19 Linked to Increased Hospital Admission Rate
84 Understanding Clinical Considerations for Patients With Both COPD, Cardiovascular Disease
85 Hospital treatment of severe acute exacerbation of chronic obstructive pulmonary disease in COVID-19 situation: back to basics
86 Lung Development May Explain Who Is at Higher Risk for COPD
87 Asthma & COPD Market is Booming Worldwide By Top Emerging Key Players: GSK, Novartis, Merck, Abbott, Boehringer Ingelheim, AstraZeneca, Roche, Teva, Vectura, Pfizer, Mylan, Allergan, Cipla, Akorn
88 Comprehensive Report on COPD and Asthma Devices Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Flexicare Medical Limited, 3A Health Care, TaiDoc Technology Corporation, GaleMed Corporation, La Diffusion Technique
89 Opioid use in older adults with COPD can lead to respiratory harm
90 COPD: Symptoms, Stages, Causes, and More
91 Low-Dose Morphine Associated with COPD Improvement
92 Continued Cough Reflex Hypersensitivity After COPD Exacerbation Predicts More Attacks
93 $3.9M Grant Given to Move Potential COPD Treatment to Clinical Testing
94 Polygenic Risk Score Could Better Predict Severe COPD Risk
95 Coronavirus and COPD: Risks, Complications, Symptoms, and More
96 What are the symptoms of COPD? Coughing, wheezing, fatigue, and more
97 Expression of ACE2 in airways: implication for COVID‐19 risk and disease management in patients with chronic inflammatory respiratory diseases
98 Can Inhaled Corticosteroids Slow COPD Lung Function Decline?
99 COPD Patients Using Metformin Should Be Aware of Added Risks...
100 ED Visits for Asthma, COPD Spike Before Thunderstorms Among Medicare Beneficiaries